Fall 2023 BRP Newsletter

William Klein

Dear Colleagues,

I hope you had a terrific summer and that fall is off to a good start.

Much of 2022 around our hallways (real and virtual) was spent facilitating a scientific planning process to identify priorities in the Division of Cancer Control and Population Sciences (DCCPS). In addition to many internal discussions, the process included feedback received from our scientific community via a Request for Information. Identified priorities include data strategies, evidence-based cancer control strategy research, digital health, modifiable risk factors, and more. These priorities and more are highlighted in the 2022 DCCPS Overview and Highlights, New Reflections on Cancer Control.

Working groups have since convened across the division, with future directions to accelerate scientific progress and increase the impact of DCCPS-sponsored research. Of note, these six priorities do not replace others in our existing portfolio, and some clearly overlap with portions of that portfolio; we simply hope to build more capacity in each of these areas.

Within BRP, I am delighted to announce that Dr. Neal Freedman has joined as branch chief of the Tobacco Control Research Branch. Dr. Freedman was previously a senior investigator in the Metabolic Epidemiology Branch of the Division of Cancer Epidemiology & Genetics. We thank Dr. Michele Bloch for her outstanding work in this role over the last 10 years, and congratulate Michele on her retirement.

On a broader NCI level, Director Dr. Monica Bertagnolli released the National Cancer Plan, outlining eight goals that must be achieved to prevent cancer, reduce deaths from cancer, and ensure the best possible quality of life for people living with cancer. The National Cancer Plan includes a set of strategies associated with each goal, and a call to action that everyone – every organization and individual – do their part to help end cancer as we know it.

Dr. Martica (Tica) Hall HeadshotWe share our condolences with all who knew Dr. Martica (Tica) Hall. Dr. Hall was a professor of psychiatry at the University of Pittsburgh, and past president of the American Psychosomatic Society (2012-13) and the Academy of Behavioral Medicine Research (2012-13). Please see Dr. Tica Hall’s in memoriam published by the University of Pittsburgh here.

In this issue, you’ll see we narrowed down our focus to sections that our statistics show have been most viewed by our readers of past issues. We include funding opportunities that have been posted since our last newsletter, awards and recognitions, career and training opportunities, and resources, such as the newly released HINTS Data, the Annual Report to the Nation on the Status of Cancer and updates to the NIH Data Management and Sharing (DMS) standard and accompanying website.

We have removed upcoming events from this issue, but you can always find them on our website.

We’d appreciate your feedback on both the new newsletter format and content. And as a reminder, feel free to manage your BRP newsletter subscription at any time, but we hope you find the information beneficial. If you’re on social media, follow us on X (formerly Twitter) at @NCIBehaviors, as well as our division’s new LinkedIn page.

All the best, 
Bill Klein 
Associate Director

BRP-relevant Funding Opportunities

Updates to Funding Opportunity Terminology 
NOT-OD-23-109 
The purpose of this notice is to notify the extramural community that NIH is transitioning to updated terminology regarding funding opportunities to better align with the Uniform Administrative Requirements as outlined in 2 CFR Part 200. Effective immediately, NIH will use the term notice of funding opportunity (NOFO) to refer to formal announcements of the availability of Federal funding through a financial assistance program. Previously, such announcements were referred to as funding opportunity announcements (FOAs). See the NIH Grants & Funding Glossary for the full definition. NIH is currently updating websites, documents, and other resources to reflect the new terminology.

Request for Information (RFI): Inviting Comments and Suggestions on Updating the NIH Mission Statement 
NOT-OD-23-163 
NIH Contact: RFIMissionStatement@nih.gov 
Posted: August 25, 2023 
Expires: November 24, 2023

RFI: Inviting Comments and Suggestions on Opportunities and Challenges for the Collection, Use, and Sharing of Real-World Data (RWD) including Electronic Health Records, for NIH Supported Biomedical and Behavioral Research 
NOT-OD-23-180 
NIH Contact: RWD-rfi@od.nih.gov 
Posted: September 14, 2023 
Expires: December 14, 2023

Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required) 
RFA-OD-23-021 
NCI Contact: Maria Roditis 
Posted: August 02, 2023 
Expires: December 07, 2023 
Pre-application webinar and FAQs

Tobacco Regulatory Science (R01 Clinical Trial Optional) 
RFA-OD-23-017 
NCI Contact: Rachel Grana Mayne 
Posted: May 04, 2023 
Expires: May 05, 2025

Leveraging Social Networks to Promote Widespread Behavior Change 
RFA-AG-24-026 (R34 Clinical Trial Optional) 
RFA-AG-24-025 (R01 Clinical Trial Optional) 
NCI Contact: Jennifer Guida 
Posted: June 08, 2023 
Expires: November 04, 2023 
Pre-application recorded webinar

Mentored Research Scientist Career Development Award in Tobacco Regulatory Research 
RFA-OD-22-023 (K01 Independent Clinical Trial Not Allowed) 
RFA-OD-22-024 (K01 Independent Clinical Trial Required) 
NCI Contact: Rachel Grana Mayne 
Posted: November 10, 2022 
Expires: March 13, 2025

Pathway to Independence Award in Tobacco Regulatory Research 
RFA-OD-22-025 (K99/R00 Independent Clinical Trial Not Allowed) 
RFA-OD-22-026 (K99/R00 Independent Clinical Trial Required) 
NCI Contact: Rachel Grana Mayne 
Posted: November 10, 2022 
Expires: March 13, 2025

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) 
PAR-23-244 
NCI Contacts: David Berrigan and Heather D’Angelo 
Posted: August 14, 2023 
Expires: January 08, 2027 
Pre-application webinar

Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) 
PAR-23-273 
NCI Contact: Rebecca Ferrer 
Posted: August 11, 2023 
Expires: May 08, 2026

Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) 
PA-20-184 
NCI Contact: Rebecca Ferrer 
Posted: May 05, 2020 
Expires: May 08, 2024 
Brief video

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes 
PAR-23-254 (R01 Clinical Trial Not Allowed) 
PAR-23-255 (R21 Clinical Trial Not Allowed) 
NCI Contact: Melissa Rotunno 
Posted: August 01, 2023 
Expires: September 08, 2026

Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) 
PAR-22-256 
BRP Contact: Susan Czajkowski 
Posted: November 23, 2022 
Expires: November 18, 2025

NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional) 
PAR-23-058 
NCI Contact: Research Program Contacts 
Posted: December 05, 2022 
Expires: January 08, 2026

Notice of NIH Participation in the National Science Foundation Solicitation NSF 23-614: Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). Verbiage on this funding opportunity predates this guidance.)
NOT-OD-23-165 
NCI Contact: Dana Wolff-Hughes 
Posted: August 28, 2023 
Expires: November 09, 2023 
Pre-application webinar

Notice of Special Interest (NOSI) Epidemiology and Prevention in Alcohol Research 
NOT-AA-23-018 
NCI Contacts: David Berrigan and Tanya Agurs-Collins 
Posted: August 25, 2023 
Expires: September 06, 2026

NOSI: Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities 
NOT-HL-23-083 
NCI Contact: Robin Vanderpool 
Posted: May 26, 2023 
Expires: October 19, 2026

Notice of Change to Application Due Dates for PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) 
NOT-CA-23-024 
NCI Contacts: Mukesh Verma and Tanya Agurs-Collins 
Posted: December 14, 2022 
Expires: November 09, 2024 
Frequently Asked Questions

NOSI: Technology Development for Cancer Control and Population Science Research 
NOT-CA-23-037 
NCI Contact: Kelly Crotty 
Posted: January 18, 2023 
Expires: December 31, 2024

NOSI: Mechanisms Driving Obesity and Prostate Cancer Risk 
NOT-CA-23-089 
NCI Contacts: Howard Parnes and Edward Sauter 
Posted: August 31, 2023 
Expires: September 08, 2024

Awards and Recognition

BRP Senior Scientist Dr. Paul Han was selected for a 2022-2023 Fulbright US Scholar Program Award. Dr. Han is conducting research in Norway to understand and improve the management of uncertainty in medical practice and education.

 

BRP Branch Chief Dr. Robin Vanderpool has been appointed to the editorial board of CDC’s peer-reviewed journal, Preventing Chronic Disease. Her appointment term is from 2023-2026.

 

BRP Branch Chief Dr. Neal Freedman was elected to the prestigious American Epidemiological Society, with the narrative citing Dr. Freedman as nationally and internationally recognized for major contributions to liver cancer, gastrointestinal cancer, and tobacco epidemiology, and for conducting novel and highly collaborative studies that have substantial public health impact.

Career and Training Opportunities

Cancer Research Training Award Fellowship in Tobacco Control and Surveillance Research 
Read the position description.

Cancer Research Training Award Fellowship in Tobacco Cessation Research 
Read the position description.

Post-Doctoral Fellowship in Health Behaviors Research 
Read the position description.

Project Management Fellowship in Basic Biobehavioral and Psychological Sciences 
Read the position description.

Health Communication Fellowship in Behavioral Research 
Read the position description.

Resources

Updated Classification of Laws Associated with School Students Dataset and Visualization Tools Now Available

The 2021 update to the Classification of Laws Associated with School Students (CLASS) database was recently released. CLASS uses a scoring system to code state laws in school physical education, nutrition, and sun safety efforts for elementary, middle, and high school levels. Data are available from 2003-2021. Users can download comprehensive datasets or generate maps, tables, and charts to visualize specific topic areas by state and year. Access CLASS data and resources.

Updated Cancer Trends Progress Report Now Available

The August 2023 Update to the Cancer Trends Progress report was recently released. From prevention to end of life, the site offers trends by sex, age, and income, education level, and more, and displays them in relation to Healthy People 2030 targets, where they are available. New measures this year include Cancer Survivors and UV Exposure, Perfluoroalkyl and Polyfluoroalkyl Substances, Healthy Eating Index, Tobacco Company Marketing Expenditures for E-Cigarettes, and Systemic Therapy Treatment for both Bladder and Kidney Cancers. View the Cancer Trends Progress Report.

HINTS 6 (2022) Data, HINTS SEER (2021) Restricted Use Data, and HINTS Data Linkage Project 2020 Restricted Use Data Now Available for Download

HINTS 6 (2022) data are now available for download. In addition to the traditional items on health communication, the use of digital technology, and cancer risk awareness that HINTS is known for, HINTS 6 (2022) also covers new topics, such as social media and misinformation, telehealth, and the social determinants of health. HINTS 6 (2022) was field from March through November 2022 (N=6,252). The public use dataset is available in SAS, SPSS, STATA, and R formats. View HINTS 6 (2022).

Health Information National Trends Survey (HINTS)-SEER (2021) Restricted-Use data are now available to download on the HINTS website. View HINTS-SEER (2021).

Health Information National Trends Survey (HINTS)-SEER (2021) Restricted-Use data are now available via request to download on the HINTS website. View HINTS Data Linkage Project 2020.

Annual Report to the Nation on the Status of Cancer

The American Cancer Society, Centers for Disease Control and Prevention, North American Association of Central Cancer Registries, and the NCI released the Annual Report to the Nation on the Status of Cancer. The report provides an update of rates for new cases and deaths as well as trends for the most common cancers in the United States. Access the report.

The Annual Report to the Nation on the Status of Cancer Part 2 is also now available. This report is the largest study to date using population-based data from central cancer registries to assess the effect of the COVID-19 pandemic on the number of newly diagnosed cancer cases in the US. View the press release. Access the report.

New Population Assessment of Tobacco and Health (PATH) Study Data Files Available from Wave 6

The NIH National Institute on Drug Abuse and the FDA Center for Tobacco Products announced the release of the Wave 6 Public-Use File from the PATH Study. These Wave 6 files contain questionnaire data collected between March 2021 and November 2021. In addition, Wave 5.5 Ever/Never Special Collection Public-Use Files are not available along with updated Master Linkage Files. Access PATH Study data.

Connect With Us